Login
$HSIC
$84.96 -$1.26 (1.46%) Live

$HSIC SEC Filings

Filed On Filing
16 Nov 2026 8-K: Regulation FD Disclosure

Indicate by check mark whether the registrant is an emerging growth

12 Nov 2026 SCHEDULE 13G/A
06 Nov 2026 Form 3: Caprais Emmanuel, SVP & Chief Financial Officer

Holds 0 shares of No Securities Beneficially Owned

03 Nov 2026 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D)
03 Nov 2026 8-K: Results of Operations and Financial Condition

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare

08 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

This Restrictive Covenant, Confidentiality and Inventions Agreement (“Agreement”) is made and entered into effective as October 12, 2026, by and between Henry Schein, Inc., a Delaware corporation headquartered in New York (the “Company”)...

22 Sep 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

The Other Subsidiary Borrowers from Time to Time Parties Hereto,

09 Sep 2026 Form 4: Albertini Andrea, CEO, Global Dist. & Tech.

Gave up 603 shares to cover exercise price or tax ($53.6K) · Returned 3,984 shares to the issuer

14 Aug 2026 144
06 Aug 2026 SCHEDULE 13G
04 Aug 2026 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D)
04 Aug 2026 8-K: Results of Operations and Financial Condition

solutions to office-based dental and medical practitioners, today reported financial results for the second quarter ended June

30 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

MELVILLE, N.Y., July 30, 2026 – Henry Schein, Inc. (Nasdaq: HSIC) announced today that it is creating the Henry Schein Leadership Team (HSLT) to replace its Executive Management Committee. The Company will also integrate its global suppl...

30 Jun 2026 144
18 Jun 2026 ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE, SAVINGS, AND SIMILAR PLANS
16 Jun 2026 144
15 Jun 2026 Form 4: Daniel William K, Director

Received 2,215 shares as a grant or award

29 May 2026 SPECIALIZED DISCLOSURE REPORT FILED PURSUANT TO SECTION 1502 OF THE DODD-FRANK W
28 May 2026 Form 3: Murphy Kelly Ann, SVP & General Counsel

Holds 34,812 shares of Common Stock, par value $0.01 per share

26 May 2026 Form 4/A: Bergman Stanley M, Former Director

Gave 50 shares as a gift

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support